6,804 reports of this reaction
1.9% of all LEVONORGESTREL reports
#13 most reported adverse reaction
PELVIC PAIN is the #13 most commonly reported adverse reaction for LEVONORGESTREL, manufactured by Bayer HealthCare Pharmaceuticals Inc.. There are 6,804 FDA adverse event reports linking LEVONORGESTREL to PELVIC PAIN. This represents approximately 1.9% of all 357,584 adverse event reports for this drug.
Patients taking LEVONORGESTREL who experience pelvic pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PELVIC PAIN is a less commonly reported adverse event for LEVONORGESTREL, but still significant enough to appear in the safety profile.
In addition to pelvic pain, the following adverse reactions have been reported for LEVONORGESTREL:
The following drugs have also been linked to pelvic pain in FDA adverse event reports:
PELVIC PAIN has been reported as an adverse event in 6,804 FDA reports for LEVONORGESTREL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PELVIC PAIN accounts for approximately 1.9% of all adverse event reports for LEVONORGESTREL, making it a notable side effect.
If you experience pelvic pain while taking LEVONORGESTREL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.